{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:32:42Z","timestamp":1794000762780,"version":"4.8.0"},"reference-count":165,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"publisher","award":["20230204101YY"],"award-info":[{"award-number":["20230204101YY"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008868","name":"Jiangsu Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["20240402011GH"],"award-info":[{"award-number":["20240402011GH"]}],"id":[{"id":"10.13039\/501100008868","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.mtbio.2024.101381","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T03:20:45Z","timestamp":1733455245000},"page":"101381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Tailoring cell-inspired biomaterials to fuel cancer therapy"],"prefix":"10.1016","volume":"30","author":[{"given":"Qi-Hui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Rui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Zhong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9019-6614","authenticated-orcid":false,"given":"Wen-Zhi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mtbio.2024.101381_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-021-01096-0","article-title":"Nanomaterials for cancer therapy: current progress and perspectives","volume":"14","author":"Cheng","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.mtbio.2024.101381_bib2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1201\/9780429399039-2","article-title":"Nanocarriers as an emerging platform for cancer therapy","author":"Peer","year":"2020","journal-title":"Nano-Enabled Med. Appl"},{"key":"10.1016\/j.mtbio.2024.101381_bib3","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jcis.2023.07.163","article-title":"A nanoparticle composed of totally hospital-available drugs and isotope for fluorescence\/SPECT dual-modal imaging-guided photothermal therapy to inhibit tumor metastasis","volume":"651","author":"Deng","year":"2023","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.mtbio.2024.101381_bib4","article-title":"Biomaterial-based in situ cancer vaccines","volume":"36","author":"Bo","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2024.101381_bib5","doi-asserted-by":"crossref","first-page":"7326","DOI":"10.1021\/acs.chemrev.2c00822","article-title":"Rational design of biomaterials to potentiate cancer thermal therapy","volume":"123","author":"Zhu","year":"2023","journal-title":"Chem. Rev."},{"key":"10.1016\/j.mtbio.2024.101381_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s44222-022-00004-6","article-title":"Biomaterials tools to modulate the tumour microenvironment in immunotherapy","volume":"1","author":"Chao","year":"2023","journal-title":"Nat. Rev. Bioengineer"},{"key":"10.1016\/j.mtbio.2024.101381_bib7","first-page":"108060","article-title":"Dentin-desensitizing biomaterials. Chin","volume":"34","author":"Wang","year":"2023","journal-title":"Chem. Lett."},{"key":"10.1016\/j.mtbio.2024.101381_bib8","first-page":"110146","article-title":"Glycoengineering-assistant biomineralization for tumor blockade therapy","author":"Liu","year":"2024","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.mtbio.2024.101381_bib9","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41578-023-00535-3","article-title":"Biomaterial-based platforms for tumour tissue engineering","volume":"8","author":"Curvello","year":"2023","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.mtbio.2024.101381_bib10","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1039\/D2CS00352J","article-title":"Bioactive inorganic nanomaterials for cancer theranostics","volume":"52","author":"Pei","year":"2023","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.mtbio.2024.101381_bib11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.nantod.2019.03.006","article-title":"Inherent multifunctional inorganic nanomaterials for imaging-guided cancer therapy","volume":"26","author":"Ju","year":"2019","journal-title":"Nano Today"},{"key":"10.1016\/j.mtbio.2024.101381_bib12","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1039\/D0CS00178C","article-title":"Multifunctional metal\u2013organic framework heterostructures for enhanced cancer therapy","volume":"50","author":"Liu","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.mtbio.2024.101381_bib13","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.mattod.2022.05.024","article-title":"Current trends in stimuli-responsive nanotheranostics based on metal\u2013organic frameworks for cancer therapy","volume":"57","author":"Oroojalian","year":"2022","journal-title":"Mater. Today"},{"key":"10.1016\/j.mtbio.2024.101381_bib14","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jconrel.2023.09.039","article-title":"Biomaterials-enhanced bioactive agents to efficiently block spinal metastases of cancers","volume":"363","author":"Liu","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2024.101381_bib15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jconrel.2024.08.047","article-title":"Melittin-incorporated nanomedicines for enhanced cancer immunotherapy","volume":"375","author":"Duan","year":"2024","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2024.101381_bib16","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nm.3653","article-title":"Preparing the ground for tissue regeneration: from mechanism to therapy","volume":"20","author":"Forbes","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.mtbio.2024.101381_bib17","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1021\/accountsmr.2c00147","article-title":"Self-adaptive nanomaterials for rational drug delivery in cancer therapy","volume":"3","author":"Yang","year":"2022","journal-title":"Acc. Mater. Res."},{"key":"10.1016\/j.mtbio.2024.101381_bib18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1146\/annurev.immunol.021908.132544","article-title":"Immune therapy for cancer","volume":"27","author":"Dougan","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.mtbio.2024.101381_bib19","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/nsr\/nwz037","article-title":"Cell membrane-covered nanoparticles as biomaterials","volume":"6","author":"Xuan","year":"2019","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.mtbio.2024.101381_bib20","doi-asserted-by":"crossref","first-page":"114394","DOI":"10.1016\/j.addr.2022.114394","article-title":"Jinliang PengCell-based drug delivery systems and their in vivo fate","volume":"187","author":"Yang","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mtbio.2024.101381_bib21","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jconrel.2020.07.043","article-title":"Immune cells as tumor drug delivery vehicles","volume":"327","author":"Combes","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2024.101381_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.34133\/bmef.0055","article-title":"Brain-targeted drug delivery platforms for ischemic stroke therapy","volume":"5","author":"Zhang","year":"2024","journal-title":"BME Front"},{"key":"10.1016\/j.mtbio.2024.101381_bib23","doi-asserted-by":"crossref","first-page":"20230019","DOI":"10.1002\/EXP.20230019","article-title":"Manipulating calcium homeostasis with nanoplatforms for enhanced cancer therapy","volume":"4","author":"Feng","year":"2024","journal-title":"Exploration"},{"key":"10.1016\/j.mtbio.2024.101381_bib24","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","article-title":"The tumour microenvironment in pancreatic cancer\u2014clinical challenges and opportunities","volume":"17","author":"Ho","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.mtbio.2024.101381_bib25","first-page":"427","article-title":"Biochemical hallmarks-targeting antineoplastic nanotherapeutics","volume":"36","author":"Han","year":"2024","journal-title":"Bio. Mater"},{"key":"10.1016\/j.mtbio.2024.101381_bib26","doi-asserted-by":"crossref","first-page":"10920","DOI":"10.1021\/acs.chemrev.3c00062","article-title":"Tumor abnormality-oriented nanomedicine design","volume":"123","author":"Zhou","year":"2023","journal-title":"Chem. Rev."},{"key":"10.1016\/j.mtbio.2024.101381_bib27","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41571-021-00539-4","article-title":"Therapeutic targeting of the hypoxic tumour microenvironment","volume":"18","author":"Singleton","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.mtbio.2024.101381_bib28","doi-asserted-by":"crossref","first-page":"20220002","DOI":"10.1002\/EXP.20220002","article-title":"Recent development of pH-responsive theranostic nanoplatforms for magnetic resonance imaging-guided cancer therapy","volume":"3","author":"Li","year":"2023","journal-title":"Exploration"},{"key":"10.1016\/j.mtbio.2024.101381_bib29","first-page":"20","volume":"4","author":"Yang","year":"2023","journal-title":"Nanoantidotes: A Detoxification System More Applicable to Clinical Practice. BME Front"},{"key":"10.1016\/j.mtbio.2024.101381_bib30","first-page":"e1985","article-title":"Bioactive poly(amino acid)s for multi-modal cancer therapy. WIREs Nanomed","volume":"16","author":"Yang","year":"2024","journal-title":"Nanobiotechnol"},{"key":"10.1016\/j.mtbio.2024.101381_bib31","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jconrel.2022.05.056","article-title":"Luo,Preparation and application of pH-responsive drug delivery systems","volume":"348","author":"Ding","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2024.101381_bib32","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-021-00496-y","article-title":"Anti-angiogenic agents\u2014overcoming tumour endothelial cell anergy and improving immunotherapy outcomes","volume":"18","author":"Huinen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.mtbio.2024.101381_bib33","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mtbio.2024.101381_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-020-01666-z","article-title":"Cancer-associated adipocytes: emerging supporters in breast cancer","volume":"39","author":"Zhao","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.mtbio.2024.101381_bib35","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","article-title":"Systemic immunity in cancer","volume":"21","author":"Hiam-Galvez","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mtbio.2024.101381_bib36","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41568-021-00366-w","article-title":"Cancer stem cell\u2013immune cell crosstalk in tumour progression","volume":"21","author":"Bayik","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mtbio.2024.101381_bib37","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0140-6736(20)30164-1","article-title":"Small molecules, big impact: 20 years of targeted therapy in oncology","volume":"395","author":"Bedard","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.mtbio.2024.101381_bib38","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41571-020-0382-2","article-title":"The adenosine pathway in immuno-oncology","volume":"17","author":"Allard","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.mtbio.2024.101381_bib39","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","article-title":"The role of ROS in tumour development and progression","volume":"22","author":"Cheung","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.mtbio.2024.101381_bib40","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/nsr\/nwaa034","article-title":"Strategies for engineering advanced nanomedicines for gas therapy of cancer","volume":"7","author":"Wang","year":"2020","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.mtbio.2024.101381_bib41","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41568-021-00417-2","article-title":"Connecting copper and cancer: from transition metal signalling to metalloplasia","volume":"22","author":"Ge","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mtbio.2024.101381_bib42","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jconrel.2019.07.004","article-title":"Enzyme responsive drug delivery systems in cancer treatment","volume":"308","author":"Shahriari","year":"2019","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2024.101381_bib43","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","article-title":"The role of non-coding RNAs in oncology","volume":"179","author":"Slack","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.mtbio.2024.101381_bib44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41571-021-00564-3","article-title":"Tumour burden and efficacy of immune-checkpoint inhibitors","volume":"19","author":"Dall'Olio","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.mtbio.2024.101381_bib45","doi-asserted-by":"crossref","first-page":"11129","DOI":"10.1021\/nn404853z","article-title":"Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells","volume":"7","author":"Anselmo","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2024.101381_bib46","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jconrel.2014.03.050","article-title":"Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles","volume":"190","author":"Anselmo","year":"2014","journal-title":"J. controlled release"},{"key":"10.1016\/j.mtbio.2024.101381_bib47","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1007\/s11095-009-9943-x","article-title":"Accelerated blood clearance phenomenon upon repeated injection of PEG-modified PLA-nanoparticles","volume":"26","author":"Ishihara","year":"2009","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.mtbio.2024.101381_bib48","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1470-8744.1991.tb00143.x","article-title":"Encapsulation by hypotonic dialysis in human erythrocytes: a diffusion or endocytosis process","volume":"13","author":"DeLoach","year":"1991","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.mtbio.2024.101381_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1470-8744.1998.tb00505.x","article-title":"Erythrocyte engineering for drug delivery and targeting","volume":"28","author":"Magnani","year":"1998","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.mtbio.2024.101381_bib50","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jconrel.2013.05.032","article-title":"Human erythrocytes as drug carriers: loading efficiency and side effects of hypotonic dialysis, chlorpromazine treatment and fusion with liposomes","volume":"170","author":"Favretto","year":"2013","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2024.101381_bib51","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jconrel.2013.12.019","article-title":"Cell-penetrating peptides meditated encapsulation of protein therapeutics into intact red blood cells and its application","volume":"176","author":"He","year":"2014","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2024.101381_bib52","doi-asserted-by":"crossref","first-page":"2403422","DOI":"10.1002\/smll.202403422","article-title":"The evolution of microfluidic-based drug-loading techniques for cells and their derivatives","author":"Tong","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.mtbio.2024.101381_bib53","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/jps.22395","article-title":"Soliman Mohammadi-SamaniEncapsulation of valproate-loaded hydrogel nanoparticles in intact human erythrocytes: a novel nano-cell composite for drug delivery","volume":"100","author":"Hamidi","year":"2011","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.mtbio.2024.101381_bib54","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s11274-019-2731-9","article-title":"What makes a good new therapeutic L-asparaginase?","volume":"35","author":"Beckett","year":"2019","journal-title":"World J. Microbiol. Biotechnol."},{"key":"10.1016\/j.mtbio.2024.101381_bib55","first-page":"392","article-title":"Red blood cell-encapsulated L-asparaginase: potential therapy of patients with asparagine synthetase deficient acute myeloid leukemia. Protein Pept","volume":"20","author":"Vaidehi","year":"2013","journal-title":"Lett."},{"key":"10.1016\/j.mtbio.2024.101381_bib56","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1021\/acs.accounts.4c00293","article-title":"Engineering cells for cancer therapy","volume":"57","author":"Liu","year":"2024","journal-title":"Accounts of Chemical Research"},{"key":"10.1016\/j.mtbio.2024.101381_bib57","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nrc3565","article-title":"Gene-engineered T cells for cancer therapy","volume":"13","author":"Kershaw","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mtbio.2024.101381_bib58","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ccell.2020.07.005","article-title":"Engineering CAR-T cells for next-generation cancer therapy","volume":"38","author":"Hong","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mtbio.2024.101381_bib59","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.1016\/j.cell.2024.08.029","article-title":"Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy","volume":"187","author":"Baldwin","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.mtbio.2024.101381_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2020.01.036","article-title":"Cell membrane-camouflaged nanoparticles as drug carriers for cancer therapy","volume":"105","author":"Xu","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.mtbio.2024.101381_bib61","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1039\/D0CS00152J","article-title":"Cell primitive-based biomimetic functional materials for enhanced cancer therapy","volume":"50","author":"Luo","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.mtbio.2024.101381_bib62","first-page":"2103790","article-title":"Platforms for cancer vaccines. Adv","volume":"34","author":"Liu","year":"2022","journal-title":"Mater"},{"key":"10.1016\/j.mtbio.2024.101381_bib63","doi-asserted-by":"crossref","first-page":"2201412","DOI":"10.1002\/smtd.202201412","article-title":"Biomimetic active materials guided immunogenic cell death for enhanced cancer immunotherapy","volume":"7","author":"Huang","year":"2023","journal-title":"Small Methods"},{"key":"10.1016\/j.mtbio.2024.101381_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-021-01141-y","article-title":"Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer","volume":"14","author":"Weng","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.mtbio.2024.101381_bib65","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41573-022-00410-w","article-title":"Therapeutically harnessing extracellular vesicles","volume":"21","author":"Cheng","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mtbio.2024.101381_bib66","article-title":"Reversible zwitterionic coordination enables rapid, high-yield, and high-purity isolation of extracellular vesicles from biofluids","volume":"9","author":"Li","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.mtbio.2024.101381_bib67","doi-asserted-by":"crossref","first-page":"13633","DOI":"10.1021\/acs.analchem.9b02834","article-title":"Encapsulating a single nanoprobe in a multifunctional nanogel for high-fidelity imaging of caspase activity in vivo","volume":"91","author":"Li","year":"2019","journal-title":"Anal. Chem."},{"key":"10.1016\/j.mtbio.2024.101381_bib68","doi-asserted-by":"crossref","first-page":"7354","DOI":"10.1039\/C8TB02301H","article-title":"Platelets and their biomimetics for regenerative medicine and cancer therapies","volume":"6","author":"Li","year":"2018","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.mtbio.2024.101381_bib69","first-page":"1777","article-title":"Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents. Blood","volume":"131","author":"Xu","year":"2018","journal-title":"The Journal of the American Society of Hematology"},{"key":"10.1016\/j.mtbio.2024.101381_bib70","doi-asserted-by":"crossref","first-page":"e202403541","DOI":"10.1002\/anie.202403541","article-title":"Platelet-drug conjugates engineered via one-step fusion approach for metastatic and postoperative cancer treatment","volume":"63","author":"Zhao","year":"2024","journal-title":"Angew. Chem., Int. Ed."},{"key":"10.1016\/j.mtbio.2024.101381_bib71","first-page":"26","article-title":"Nanoengineered sonosensitive platelets for synergistically augmented sonodynamic tumor therapy by glutamine deprivation and cascading thrombosis","volume":"24","author":"Zhou","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.mtbio.2024.101381_bib72","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s12094-021-02771-x","article-title":"Platelets for cancer treatment and drug delivery","volume":"24","author":"Xiao","year":"2022","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.mtbio.2024.101381_bib73","first-page":"3192","article-title":"Platelets and extracellular vesicles and their cross talk with cancer. Blood","volume":"137","author":"Lazar","year":"2021","journal-title":"The Journal of the American Society of Hematology"},{"key":"10.1016\/j.mtbio.2024.101381_bib74","doi-asserted-by":"crossref","DOI":"10.1126\/scirobotics.aba6137","article-title":"Enzyme-powered Janus platelet cell robots for active and targeted drug delivery","volume":"5","author":"Tang","year":"2020","journal-title":"Sci. Robot."},{"key":"10.1016\/j.mtbio.2024.101381_bib75","doi-asserted-by":"crossref","first-page":"2104912","DOI":"10.1002\/smll.202104912","article-title":"Engineered platelet-based micro\/nanomotors for cancer therapy","volume":"17","author":"Li","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.mtbio.2024.101381_bib76","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1021\/acs.nanolett.1c00168","article-title":"Platelet-membrane-coated nanoparticles enable vascular disrupting agent combining anti-angiogenic drug for improved tumor vessel impairment","volume":"21","author":"Li","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.mtbio.2024.101381_bib77","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.tibtech.2020.10.004","article-title":"Prospective therapeutic applications of platelet extracellular vesicles","volume":"39","author":"Johnson","year":"2021","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.mtbio.2024.101381_bib78","first-page":"1026386","article-title":"Platelets and platelet extracellular vesicles in drug delivery therapy: a review of the current status and future prospects. Front","volume":"13","author":"Dai","year":"2022","journal-title":"Pharmacol"},{"key":"10.1016\/j.mtbio.2024.101381_bib79","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3390\/pharmaceutics15030953","article-title":"Clinically expired platelet concentrates as a source of extracellular vesicles for targeted anti-cancer drug delivery","volume":"15","author":"Meliciano","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2024.101381_bib80","doi-asserted-by":"crossref","first-page":"113959","DOI":"10.1016\/j.bcp.2020.113959","article-title":"Drug uptake-based chemoresistance in breast cancer treatment","volume":"177","author":"Muley","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.mtbio.2024.101381_bib81","doi-asserted-by":"crossref","first-page":"2237134","DOI":"10.1080\/09537104.2023.2237134","article-title":"Platelet extracellular vesicles are efficient delivery vehicles of doxorubicin, an anti-cancer drug: preparation and in vitro characterization","volume":"34","author":"Wu","year":"2023","journal-title":"Platelets"},{"key":"10.1016\/j.mtbio.2024.101381_bib82","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1160\/TH06-06-0313","article-title":"Platelet microparticle membranes have 50-to 100-fold higher specific procoagulant activity than activated platelets","volume":"97","author":"Sinauridze","year":"2007","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.mtbio.2024.101381_bib83","first-page":"42","article-title":"A review of commercially available thrombin generation assays. Res. Pract. Thromb","volume":"2","author":"Kintigh","year":"2018","journal-title":"Haemostasis"},{"key":"10.1016\/j.mtbio.2024.101381_bib84","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.3389\/fimmu.2018.02723","article-title":"Large extracellular vesicles: have we found the holy grail of inflammation?","volume":"9","author":"S\u0142omka","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mtbio.2024.101381_bib85","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biomaterials.2015.10.046","article-title":"Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles","volume":"76","author":"Li","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.mtbio.2024.101381_bib86","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.18632\/oncotarget.27223","article-title":"Engineered human platelet-derived microparticles as natural vectors for targeted drug delivery","volume":"10","author":"Kailashiya","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.mtbio.2024.101381_bib87","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jconrel.2006.06.032","article-title":"Applications of carrier erythrocytes in delivery of biopharmaceuticals","volume":"118","author":"Hamidi","year":"2007","journal-title":"J. controlled release"},{"issue":"2","key":"10.1016\/j.mtbio.2024.101381_bib88","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0300-9084(98)80024-2","article-title":"Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages. A review","volume":"80","author":"Bratosin","year":"1998","journal-title":"Biochimie"},{"key":"10.1016\/j.mtbio.2024.101381_bib89","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1040-8428(98)00015-8","article-title":"Use of L-asparaginase in childhood ALL. Critical rev","volume":"28","author":"M\u00fcller","year":"1998","journal-title":"oncology\/hematology"},{"key":"10.1016\/j.mtbio.2024.101381_bib90","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1365-2141.2011.08588.x","article-title":"l-asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: results of the GRASPALL 2005-01 randomized trial","volume":"153","author":"Domenech","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mtbio.2024.101381_bib91","first-page":"811","volume":"90","author":"Hunault-Berger","year":"2015","journal-title":"AP hase 2 study of L-asparaginase encapsulated in erythrocytes in elderly patients with P hiladelphia chromosome negative acute lymphoblastic leukemia: the GRASPALL\/GRAALL-SA 2-2008 study.Am. J. Hematol"},{"key":"10.1016\/j.mtbio.2024.101381_bib92","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2217\/ijh-2016-0002","article-title":"Erythrocyte encapsulated l-asparaginase (GRASPA) in acute leukemia","volume":"5","author":"Thomas","year":"2016","journal-title":"Int. J. Hematol. Oncol"},{"key":"10.1016\/j.mtbio.2024.101381_bib93","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1158\/0008-5472.CAN-06-2519","article-title":"Enhanced expression of asparagine synthetase under glucose-deprived conditions protects pancreatic cancer cells from apoptosis induced by glucose deprivation and cisplatin","volume":"67","author":"Cui","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.mtbio.2024.101381_bib94","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/MPA.0b013e318247d903","article-title":"Pancreatic tumor sensitivity to plasma L-asparagine starvation","volume":"41","author":"Emmanuelle","year":"2012","journal-title":"Pancreas"},{"key":"10.1016\/j.mtbio.2024.101381_bib95","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/MPA.0000000000000394","article-title":"Asparagine synthetase expression and phase I study with L-asparaginase encapsulated in red blood cells in patients with pancreatic adenocarcinoma","volume":"44","author":"Jean-Baptiste","year":"2015","journal-title":"Pancreas"},{"key":"10.1016\/j.mtbio.2024.101381_bib96","first-page":"91","article-title":"Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: an open-label, randomized Phase IIb trial. Eur","volume":"124","author":"Hammel","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.mtbio.2024.101381_bib97","doi-asserted-by":"crossref","first-page":"e202203838","DOI":"10.1002\/ange.202203838","article-title":"Of carboplatin via an erythrocyte-anchored prodrug strategy","volume":"134","author":"Yao","year":"2022","journal-title":"Angew. Chem."},{"key":"10.1016\/j.mtbio.2024.101381_bib98","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1038\/s41467-021-22898-3","article-title":"Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2024.101381_bib99","doi-asserted-by":"crossref","first-page":"2103497","DOI":"10.1002\/adma.202103497","article-title":"Engineering endogenous tumor-associated macrophage-targeted biomimetic nano-RBC to Reprogram tumor immunosuppressive microenvironment for enhanced chemo-immunotherapy","volume":"33","author":"Wang","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2024.101381_bib100","doi-asserted-by":"crossref","first-page":"13500","DOI":"10.1021\/acsnano.3c01910","article-title":"Malaria biomimetic for tumor targeted drug delivery","volume":"17","author":"Pihl","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2024.101381_bib101","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1126\/science.288.5473.2051","article-title":"Role of CD47 as a marker of self on red blood cells","volume":"288","author":"Oldenborg","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.mtbio.2024.101381_bib102","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.apsb.2019.01.011","article-title":"Nianping FengRed blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application","author":"Xia","year":"2019","journal-title":"Acta Pharm. Sin. B 9"},{"key":"10.1016\/j.mtbio.2024.101381_bib103","doi-asserted-by":"crossref","first-page":"523","DOI":"10.7150\/thno.17259","article-title":"Enhanced blood suspensibility and laser-activated tumor-specific drug release of theranostic mesoporous silica nanoparticles by functionalizing with erythrocyte membranes","volume":"7","author":"Su","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.mtbio.2024.101381_bib104","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/adfm.201504780","article-title":"Long circulation red-blood-cell-mimetic nanoparticles with peptide-enhanced tumor penetration for simultaneously inhibiting growth and lung metastasis of breast cancer","volume":"26","author":"Su","year":"2016","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.mtbio.2024.101381_bib105","doi-asserted-by":"crossref","first-page":"13211","DOI":"10.1021\/acsnano.3c00345","article-title":"J.Lv, Y. Fan, J. Feng, C. Liu, J. Guo, B. Li, X. Bai L. Zheng, Engineered enzyme-loaded erythrocyte vesicles precisely deprive tumoral nutrients to induce synergistic near-infrared-II photothermal therapy and immune activation","volume":"17","author":"Nie","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2024.101381_bib106","first-page":"2310318","article-title":"For cancer therapy. Adv","volume":"36","author":"Zhang","year":"2024","journal-title":"Mater"},{"key":"10.1016\/j.mtbio.2024.101381_bib107","doi-asserted-by":"crossref","first-page":"2301835","DOI":"10.1002\/advs.202301835","article-title":"Neutrophil-mediated tumor-targeting delivery system of oncolytic bacteria combined with ICB for melanoma lung metastasis therapy","volume":"10","author":"Liu","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.mtbio.2024.101381_bib108","doi-asserted-by":"crossref","first-page":"15542","DOI":"10.1021\/acsnano.3c02013","article-title":"Neutrophil-mediated delivery of nanocrystal drugs via photoinduced inflammation enhances cancer therapy","volume":"17","author":"Su","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2024.101381_bib109","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1021\/acsnano.2c11764","article-title":"Sensitizing tumors to immune checkpoint blockage via STING agonists delivered by tumor-penetrating neutrophil cytopharmaceuticals","volume":"17","author":"Hao","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2024.101381_bib110","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/s41467-020-14963-0","article-title":"Chemotaxis-driven delivery of nano-pathogenoids for complete eradication of tumors post-phototherapy","volume":"11","author":"Li","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2024.101381_bib111","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41551-024-01180-z","article-title":"Neutrophils bearing adhesive polymer micropatches as a drug-free cancer immunotherapy","volume":"8","author":"Kumbhojkar","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.mtbio.2024.101381_bib112","first-page":"1974","article-title":"A neutrophil mimicking metal-porphyrin-based nanodevice loaded with porcine pancreatic elastase for cancer therapy. Nat","volume":"14","author":"Cui","year":"2023","journal-title":"Commun. Now."},{"key":"10.1016\/j.mtbio.2024.101381_bib113","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1021\/acsnano.3c09499","article-title":"Advancing precision: a controllable self-synergistic nanoplatform initiating pyroptosis-based immunogenic cell death cascade for targeted tumor therapy","volume":"18","author":"Qin","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2024.101381_bib114","article-title":"Engineered neutrophil-derived exosome-like vesicles for targeted cancer therapy","volume":"8","author":"Zhang","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.mtbio.2024.101381_bib115","doi-asserted-by":"crossref","first-page":"120784","DOI":"10.1016\/j.biomaterials.2021.120784","article-title":"Inflammatory tumor microenvironment responsive neutrophil exosomes-based drug delivery system for targeted glioma therapy","volume":"273","author":"Wang","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.mtbio.2024.101381_bib116","doi-asserted-by":"crossref","first-page":"2002054","DOI":"10.1002\/adma.202002054","article-title":"Engineering macrophages for cancer immunotherapy and drug delivery","volume":"32","author":"Xia","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2024.101381_bib117","doi-asserted-by":"crossref","first-page":"9799","DOI":"10.1021\/acsnano.2c03573","article-title":"Live macrophage-delivered doxorubicin-loaded liposomes effectively treat triple-negative breast cancer","volume":"16","author":"Yang","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2024.101381_bib118","doi-asserted-by":"crossref","first-page":"14441","DOI":"10.1021\/acsnano.4c01120","article-title":"J. Wang, X. Gao, J. Xia, W. Li, P. Song, W. Zhang, F. Ge, L. Zhu, pluronic-based nanoparticles for delivery of doxorubicin to the tumor microenvironment by binding to macrophages","volume":"18","author":"Hu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2024.101381_bib119","doi-asserted-by":"crossref","first-page":"e202313968","DOI":"10.1002\/ange.202313968","article-title":"A gene-editable palladium-based bioorthogonal nanoplatform facilitates macrophage phagocytosis for tumor therapy","volume":"135","author":"Feng","year":"2023","journal-title":"Angew. Chem."},{"key":"10.1016\/j.mtbio.2024.101381_bib120","first-page":"2406140","article-title":"Dual-engineered macrophage-microbe encapsulation for metastasis immunotherapy. Adv","volume":"36","author":"Wu","year":"2024","journal-title":"Mater"},{"key":"10.1016\/j.mtbio.2024.101381_bib121","doi-asserted-by":"crossref","first-page":"10872","DOI":"10.1021\/acsnano.3c02657","article-title":"Bioengineered nanospores selectively blocking LC3-associated phagocytosis in tumor-associated macrophages potentiate antitumor immunity","volume":"17","author":"Shang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2024.101381_bib122","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1021\/acsnano.3c00041","article-title":"S.Ming-Yuen Lee, G. Chen, Ruibing WangConjugation of macrophage-mimetic microalgae and liposome for antitumor sonodynamic immunotherapy via hypoxia alleviation and autophagy inhibition","volume":"17","author":"Gao","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2024.101381_bib123","doi-asserted-by":"crossref","first-page":"2110364","DOI":"10.1002\/adma.202110364","article-title":"Zhihong LiuEngineering macrophage exosome disguised biodegradable nanoplatform for enhanced sonodynamic therapy of glioblastoma","volume":"34","author":"Wu","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2024.101381_bib124","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-024-07443-8","article-title":"Engineered CD47 protects T cells for enhanced antitumour immunity","volume":"630","author":"Yamada-Hunter","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.mtbio.2024.101381_bib125","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41563-024-01825-z","article-title":"Lyophilized lymph nodes for improved delivery of chimeric antigen receptor T cells","volume":"23","author":"Shi","year":"2024","journal-title":"Nat. Mater."},{"key":"10.1016\/j.mtbio.2024.101381_bib126","first-page":"1","article-title":"An oncolytic virus\u2013T cell chimera for cancer immunotherapy","author":"Chen","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.mtbio.2024.101381_bib127","doi-asserted-by":"crossref","first-page":"121981","DOI":"10.1016\/j.biomaterials.2022.121981","article-title":"Genetically edited T-cell membrane coated AIEgen nanoparticles effectively prevents glioblastoma recurrence","volume":"293","author":"Wang","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.mtbio.2024.101381_bib128","doi-asserted-by":"crossref","first-page":"2101110","DOI":"10.1002\/adma.202101110","article-title":"T-cell-derived nanovesicles for cancer immunotherapy","volume":"33","author":"Hong","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2024.101381_bib129","doi-asserted-by":"crossref","first-page":"16770","DOI":"10.1021\/acsnano.3c03456","article-title":"Sequential targeting hybrid nanovesicles composed of chimeric antigen receptor T-cell-derived exosomes and liposomes for enhanced cancer immunochemotherapy","volume":"17","author":"Zhu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2024.101381_bib130","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1021\/acs.nanolett.4c00425","article-title":"Dynamic hybrid module-driven NK cell stimulation and release for tumor immunotherapy","volume":"24","author":"Jiao","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.mtbio.2024.101381_bib131","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-019-0052-1","article-title":"NK cells for cancer immunotherapy","volume":"19","author":"Shimasaki","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mtbio.2024.101381_bib132","first-page":"835","article-title":"The NK cell\u2013cancer cycle: advances and new challenges in NK cell\u2013based immunotherapies. Nat","volume":"21","author":"Bald","year":"2020","journal-title":"Immunol."},{"key":"10.1016\/j.mtbio.2024.101381_bib133","series-title":"Light-Controlled Bioorthogonal Chemistry Altered Natural Killer Cell Activity for Boosted Adoptive Immunotherapy","first-page":"e202411905","author":"Liu","year":"2024"},{"key":"10.1016\/j.mtbio.2024.101381_bib134","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/s41551-021-00768-z","article-title":"Directly reprogrammed natural killer cells for cancer immunotherapy","volume":"5","author":"Kim","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.mtbio.2024.101381_bib135","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1021\/acs.nanolett.2c03928","article-title":"Dna-templated anchoring of proteins for programmable cell functionalization and immunological response","volume":"23","author":"Xiong","year":"2022","journal-title":"Nano Lett."},{"key":"10.1016\/j.mtbio.2024.101381_bib136","doi-asserted-by":"crossref","first-page":"1904495","DOI":"10.1002\/adma.201904495","article-title":"Artificial natural killer cells for specific tumor inhibition and renegade macrophage re-education","volume":"31","author":"Zou","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2024.101381_bib137","doi-asserted-by":"crossref","first-page":"2400507","DOI":"10.1002\/adfm.202400507","article-title":"3D-Printed dendritic cell vaccines for post-surgery cancer immunotherapy","volume":"34","author":"Xu","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.mtbio.2024.101381_bib138","doi-asserted-by":"crossref","first-page":"122048","DOI":"10.1016\/j.biomaterials.2023.122048","article-title":"Biomimetic dendritic polymeric microspheres induce enhanced T cell activation and expansion for adoptive tumor immunotherapy","volume":"296","author":"Yang","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.mtbio.2024.101381_bib139","doi-asserted-by":"crossref","first-page":"2205950","DOI":"10.1002\/adma.202205950","article-title":"Direct presentation of tumor-associated antigens to induce adaptive immunity by personalized dendritic cell-mimicking nanovaccines","volume":"34","author":"Zhang","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2024.101381_bib140","first-page":"2102322","article-title":"A biomimetic aggregation-induced emission photosensitizer with antigen-presenting and hitchhiking function for lipid droplet targeted photodynamic immunotherapy. Adv","volume":"33","author":"Xu","year":"2021","journal-title":"Mater"},{"key":"10.1016\/j.mtbio.2024.101381_bib141","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1021\/acsnano.2c09033","article-title":"Tumor\u2013antigen activated dendritic cell membrane-coated biomimetic nanoparticles with orchestrating immune responses promote therapeutic efficacy against glioma","volume":"17","author":"Ma","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2024.101381_bib142","doi-asserted-by":"crossref","first-page":"13992","DOI":"10.1021\/acsnano.2c03597","article-title":"Biosynthetic dendritic cell-exocytosed aggregation-induced emission nanoparticles for synergistic photodynamic immunotherapy","volume":"16","author":"Cao","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2024.101381_bib143","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jconrel.2022.11.053","article-title":"Dendritic cell derived exosomes loaded neoantigens for personalized cancer immunotherapies","volume":"353","author":"Li","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2024.101381_bib144","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc3013","article-title":"Cryo-shocked cancer cells for targeted drug delivery and vaccination","volume":"6","author":"Ci","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.mtbio.2024.101381_bib145","doi-asserted-by":"crossref","first-page":"2205462","DOI":"10.1002\/adma.202205462","article-title":"Walking dead tumor cells for targeted drug delivery against lung metastasis of triple-negative breast cancer","volume":"34","author":"Zhao","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2024.101381_bib146","doi-asserted-by":"crossref","first-page":"16620","DOI":"10.1021\/acsnano.3c02724","article-title":"Cancer cell membrane-coated nanoparticle co-loaded with photosensitizer and toll-like receptor 7 agonist for the enhancement of combined tumor immunotherapy","volume":"17","author":"Chen","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2024.101381_bib147","doi-asserted-by":"crossref","first-page":"122026","DOI":"10.1016\/j.biomaterials.2023.122026","article-title":"Tumor microenvironment targeting system for glioma treatment via fusion cell membrane coating nanotechnology","volume":"295","author":"Ma","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.mtbio.2024.101381_bib148","doi-asserted-by":"crossref","DOI":"10.1002\/ange.202304419","article-title":"Biomimetic nanocomposites camouflaged with hybrid cell membranes for accurate therapy of early-stage glioma","volume":"135","author":"Chi","year":"2023","journal-title":"Angew. Chem."},{"key":"10.1016\/j.mtbio.2024.101381_bib149","doi-asserted-by":"crossref","first-page":"7941","DOI":"10.1021\/acs.nanolett.3c01775","article-title":"Cancer cell membrane nanodiscs for antitumor vaccination","volume":"23","author":"Guo","year":"2023","journal-title":"Nano Lett."},{"key":"10.1016\/j.mtbio.2024.101381_bib150","first-page":"258","article-title":"A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo. Nat","volume":"36","author":"Li","year":"2018","journal-title":"Biotechnol."},{"key":"10.1016\/j.mtbio.2024.101381_bib151","doi-asserted-by":"crossref","first-page":"102323","DOI":"10.1016\/j.nantod.2024.102323","article-title":"Mitochondrial targeted nanomaterials for alleviating inflammation","volume":"57","author":"Cheng","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.mtbio.2024.101381_bib152","doi-asserted-by":"crossref","first-page":"8126","DOI":"10.1039\/D2CS00999D","article-title":"Synthesizing biomaterials in living organisms","volume":"52","author":"Zhang","year":"2023","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.mtbio.2024.101381_bib153","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3390\/molecules25030715","article-title":"Cell-based nanoparticles delivery systems for targeted cancer therapy: lessons from anti-angiogenesis treatments","volume":"25","author":"Torre","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.mtbio.2024.101381_bib154","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41568-023-00586-2","article-title":"mRNA-based cancer therapeutics","volume":"23","author":"Liu","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mtbio.2024.101381_bib155","first-page":"41","article-title":"mRNA vaccine for cancer immunotherapy. Mol","volume":"20","author":"Miao","year":"2021","journal-title":"cancer"},{"key":"10.1016\/j.mtbio.2024.101381_bib156","first-page":"57","article-title":"KeCurrent applications and future perspective of CRISPR\/Cas9 gene editing in cancer. Mol","volume":"21","author":"Wang","year":"2022","journal-title":"cancer"},{"key":"10.1016\/j.mtbio.2024.101381_bib157","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12943-023-01738-6","article-title":"Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy","volume":"22","author":"Liu","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.mtbio.2024.101381_bib158","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41580-023-00615-w","article-title":"The technological landscape and applications of single-cell multi-omics","volume":"24","author":"Baysoy","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.mtbio.2024.101381_bib159","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41392-022-00994-0","article-title":"Artificial intelligence in cancer target identification and drug discovery","volume":"7","author":"You","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.mtbio.2024.101381_bib160","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41578-019-0129-9","article-title":"HeilshornEngineered materials for organoid systems","volume":"4","author":"Kratochvil","year":"2019","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.mtbio.2024.101381_bib161","doi-asserted-by":"crossref","first-page":"155882","DOI":"10.1016\/j.cej.2024.155882","article-title":"The impact of emerging contaminants exposure on human health effects: a review of organoid assessment models","volume":"498","author":"Yang","year":"2024","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.mtbio.2024.101381_bib162","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.actbio.2021.01.026","article-title":"Biomaterial-guided stem cell organoid engineering for modeling development and diseases","volume":"132","author":"Hoang","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.mtbio.2024.101381_bib163","first-page":"1","article-title":"Microbial cell factories for cost-effective and high-quality cultured meat","author":"Guan","year":"2024","journal-title":"Nat. Rev. Bioeng"},{"key":"10.1016\/j.mtbio.2024.101381_bib164","doi-asserted-by":"crossref","first-page":"2304021","DOI":"10.1002\/adhm.202304021","article-title":"Tailoring biomaterials ameliorate inflammatory bone loss","volume":"13","author":"Cheng","year":"2024","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.mtbio.2024.101381_bib165","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1166\/jbn.2017.2409","article-title":"Indocyanine green-loaded gold nanoflowers@ two layers of silica nanocomposites for photothermal and photodynamic therapy of oral carcinoma","volume":"13","author":"Song","year":"2017","journal-title":"J. Biomed. Nanotechnol."}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006424004423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006424004423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T20:21:01Z","timestamp":1762633261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006424004423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":165,"alternative-id":["S2590006424004423"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2024.101381","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tailoring cell-inspired biomaterials to fuel cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2024.101381","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101381"}}